The economic benefits of FASB's recommended disclosures : evidence from the pharmaceutical industry
Year of publication: |
2008
|
---|---|
Authors: | Legoria, Joseph ; Boone, Jeffery P. ; Stammerjohan, William W. |
Published in: |
Advances in accounting : a research annual. - Amsterdam [u.a.] : Elsevier, ISSN 0882-6110, ZDB-ID 722244-0. - Vol. 24.2008, 2, p. 202-212
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Unternehmenspublizität | Corporate disclosure | Auskunftspflicht | Disclosure regulation |
-
Mazumder, Mohammed Mehadi Masud, (2019)
-
Hao, Maggie, (2017)
-
Voluntary Disclosure Practice of Pharmaceutical and Chemical Companies : Evidence from Bangladesh
Rouf, Dr. Md. Abdur, (2015)
- More ...
-
The associations among accounting program attributes, 150-hour status, and CPA exam pass rates
Boone, Jeff, (2006)
-
The economic benefits of FASB's recommended disclosures : evidence from the pharmaceutical industry
Legoria, Joseph, (2008)
-
Auditor Tenure and Audit Quality
Brooks, Li Zheng, (2011)
- More ...